Background: After superior vena cava (SVC) resection, the need for reconstruction varies among tangential resection, pericardial patch repair and prosthetic replacement. Patients undergoing complete prosthetic replacement often require a different surgical approach, intra-operative SVC cross-clamping and anticoagulation when polytetrafluoroethylene (PTFE) prosthesis is used. This study tested the hypothesis that PTFE replacement may interfere with perioperative outcome. Materials and methods: Clinical records from a series of 72 consecutive SVC resections performed between 1998 and 2008 were reviewed. Complications were classed into five categories: surgical, respiratory, cardiac, SVC system thrombosis and nerve damage. Each category of postoperative complications was considered as an outcome variable in a univariate analysis testing 12 covariates as risk factors. Covariates considered clinically relevant or statistically significant were included in the multivariate model. Results: During the considered period, 28 patients underwent total SVC resection with PTFE prosthetic replacement and 44 patients underwent SVC repair by the use of direct running suture (nine patients), stapling (30 patients) or autologous pericardial patch (five patients). Two patients died postoperatively (2.8%). Major complications were mainly due to respiratory failure, which occurred in nine cases (acute respiratory failure in five cases, recurrent atelectasis in three cases, acute respiratory distress syndrome (ARDS) in one case). In terms of overall mortality and morbidity, univariate analysis did not confirm a detrimental effect of SVC replacement as compared with SVC repair, as major postoperative complications occurred in similar proportion in both groups (respectively, 6/28, 21.4% vs 7/44, 15.9%, p = 0.54). No other risk factor was identified by univariate analysis. Conclusions: Complete prosthetic replacement does not increase overall postoperative morbidity in patients undergoing SVC resection and can be safely performed when other reconstruction techniques preclude sufficient tumour-free resection margin or compromise adequate blood flow. #
Introduction
Over the past 40 years, the surgical approach to tumours involving the superior vena cava (SVC) has evolved from pioneer and anecdotal experiences [1] into defined indications and standardised techniques, transforming a proportion of patients who were defined as inoperable into candidates for surgery with curative intent [2] [3] [4] [5] . When SVC resections are performed, long-term results depend mainly on patient selection (particularly in lung cancer patients, in which the involvement of mediastinal nodes dramatically reduces survival) [6] and on the radicality of the resection, which is the target of surgery.
The type of SVC reconstruction after resection depends on the extent of vessel defect. Two different categories of SVC reconstruction can be performed: direct repair (with or without patch) or prosthetic replacement [7] . The first technique is used when the infiltrated area of SVC is limited and a residual lumen greater than 70% of the original one can be obtained after repair, while prosthetic replacement is performed in case of more extensive infiltration.
Prosthetic replacement often requires longer operating time, careful intra-operative strategy during SVC crossclamping and the employment of prosthetic material (mainly ringed polytetrafluoroethylene, PTFE) [8] , which may predispose to graft thrombosis and/or infection. All these elements may have a direct detrimental influence on surgical complications. This study tested the hypothesis that SVC replacement by PTFE prosthesis may interfere with perioperative and postoperative outcome, as compared with direct or patch SVC repair. 
Material and methods

Population
Selection and preoperative work-up
During the considered period, SVC resection was considered in patients aged less than 70, ASA (American Society of Anesthesiologists) score class I or II, without previous history of cardiac surgery. In case of germ-cell tumours, surgery was proposed in cases of residual mass after chemotherapy or slow-growing teratoma syndrome. In cases of thymoma-infiltrating SVC, surgery was considered the first treatment, generally followed by radiotherapy in the case of uneventful recovery. In cases of SVC infiltration due to limited non-small-cell lung cancer (NSCLC), patients underwent mediastinoscopy and induction chemotherapy when mediastinal metastases were present. In cases of extensive infiltration, chemotherapy preceded surgery in all cases.
Preoperative work-up in case of pulmonary involvement consisted of spirometry and pulmonary diffusing capacity for carbon monoxide (DLCO) assessment, whole-body computed tomography (CT) scan, bronchoscopy and lung perfusion scan in severe chronic obstructive pulmonary disease (COPD) patients or in candidates for pneumonectomy. PET scan was routinely used. A predicted postoperative forced expiratory volume in 1 s (FEV1) of 30% or less was considered an absolute contraindication for surgery. In thymoma patients where myasthenia was clinically suspected, complete neurological assessment was performed and surgery was delayed until symptoms were fully controlled.
Acute SVC syndrome was never considered as an indication for urgent surgical SVC procedure.
Surgical management
The preferred surgical approach was lateral 'musclesparing' thoracotomy in lung cancer patients and right hemiclamshell approach in mediastinal tumours. In cases with involvement of the brachiocephalic vein (BCV) junction or the subclavian vein, an additional trans-manubrial approach was implemented.
Stapling or direct repair by a 3/0 polypropylene running suture was used when less than 15% of the SVC diameter was resected, usually at the azygos vein (AV) junction. An autologous pericardial patch was used for resection involving up to 50% of the SVC diameter. PTFE prosthetic replacement was used when more than 50% of the vessel was infiltrated (Fig. 1) . Whenever feasible, PTFE prosthesis was placed between one BCV and right atrial appendage (RAA) before resecting SVC to avoid cross-clamping (Figs. 2 and 3) .
To overcome the risk of cerebral oedema during SVC crossclamping maintaining an adequate artero-venous gradient, the administration of fluids and vasoactive agents was titrated to achieve a mean arterial pressure of 80 mmHg before clamping [7] . Once obtained, intravenous sodium heparin (80 UI kg À1 ) was administered, SVC clamped and resection was initiated in the absence of major hypotension.
In cavo-caval (SVC-SVC) prosthesis, the azygos vein was ligated first, the extrapericardial portion of SVC was then prepared, and finally, the intrapericardial SVC portion was exposed. When the infiltration involved one or both BCVs, the prosthesis was placed between one BCV and SVC (BCV-SVC, with cross-clamping) or between BCV and RAA (BCV-RAA, without SVC cross-clamping). Postoperative anticoagulation was maintained by subcutaneous administration of 85 UI kg À1 nadroparine every 12 h in the absence of bleeding, converted to oral anticoagulants after chest tube removal (target international normalised ratio (INR) 2.5).
ICU stay was planned for patients undergoing SVC graft replacement, pneumonectomy or for those with concomitant myasthenia gravis. The postoperative rehabilitation programme did not differ from the standard procedure. Any puncture of the upper arms was avoided. Upper arm oedema was treated by banding and elevation.
Postoperative complications
Postoperative complications were defined as any adverse event occurring in hospital or within 30 days from surgery. Complications were classed into five categories: surgical (e.g., bronchial fistula, haemorrhage, chylothorax and air leak), respiratory (e.g., respiratory failure, recurrent atelectasis, pneumonia and acute respiratory distress syndrome (ARDS)), cardiac (e.g., cardiac failure, atrial fibrillation and pulmonary embolism), SVC system thrombosis and nerve damage.
Information on events after discharge and patency of the SVC reconstructed area was collected 4 months after surgery when the first postoperative enhanced CT scan was performed.
Statistical analysis
Each category of postoperative complications was considered as an outcome variable in univariate analysis, using the following 12 covariates as risk factors: age, sex, smoking, primary tumour (pulmonary vs mediastinal) preoperative chemotherapy, preoperative radiotherapy, history of caval obstruction, respiratory function (FEV1%), duration of surgery, type of SVC reconstruction (repair vs prosthesis), type of pulmonary resection (pneumonectomy vs lesser or no resection) and blood transfusions. In the subset of SVC system thrombosis, two additional risk factors were considered: BCV reconstruction and azygos vein closure. The odds ratio and the corresponding 95% confidence intervals were reported for covariates that were considered clinically relevant or statistically significant at the 0.05 significance level (Wald chi-square test) and were then included in the final multivariate model.
Results
Preoperative data
The series was composed of 72 patients who underwent surgery for lung cancer (44 cases) or mediastinal tumours (28 cases), of which thymoma was the most common disease (11 cases) ( Table 1) .
According to the ASA stratification, 30 patients were classed ASA 1 and 42 ASA 2. Median preoperative FEV1 and FVC were 70% and 75%, respectively.
Myasthenia gravis was present in three thymoma patients and symptoms were controlled by oral pyridostigmine. In the lung cancer group, 35 patients had preoperative chemotherapy and four patients combined chemo-radiotherapy. In the mediastinal tumour group, six patients received chemotherapy before surgery and seven mediastinal radiotherapy with curative intent.
In 11 cases, radiological signs of phrenic nerve palsy were present before surgery. Eight patients had a history of SVC syndrome at the time of first diagnosis, which was resolved at the time of surgery in all but one case.
Surgical procedures
During the considered period, 28 patients underwent total SVC resection with PTFE prosthetic replacement and 44 patients underwent SVC repair by the use of direct running suture (nine patients), stapling (30 patients) or autologous pericardial patch (five patients). Graft replacement was more common in mediastinal tumours (17/28 cases, 60.1%) than in lung cancer (11/44 cases, 25%).
Lateral thoracotomy resulted as being adequate in 34 cases, while the hemi-clamshell approach was used in 38 cases. An additional trans-manubrial approach was required in seven patients.
Forty-two patients required SVC temporary cross-clamping. Median cross-clamping time was longer in cases of prosthetic replacement (45 min) than in cases of repair (28 min, p 0.04). No major clinical consequences from crossclamping were recorded, with the exception of one patient, who had a partial SVC resection with positive resection margins due to major refractory hypotension at the time of SVC closure. Six additional patients developed transient hypotension at the SVC cross-clamping, which was successfully treated by administration of fluids and vasoactive agents.
Concerning SVC replacement, SVC-SVC reconstruction was performed in eight cases, BCV-SVC reconstruction in eight cases, SVC-RAA in six cases and BCV-RAA in six cases. Distal anastomosis was performed first and reconstructions were patent at the time of chest closure in all cases.
No pulmonary resection was combined with SVC resection in 15 cases, right lobectomy was performed in 46 cases (performed with bronchoplasty in 18 cases) and pneumonectomy was required in 11 cases (implemented with carinal resection in three cases). In nine patients, angioplasty of the right pulmonary artery was required to avoid pneumonectomy (PTFE prosthetic replacement in three cases, pericardial patch in four cases and direct repair in two cases).
Postoperative complications
Two patients died postoperatively (2.8%), one after SVC replacement (3.5%) and one after SVC repair (2.2%), due to respiratory failure and acute myocardial infarction, respectively (Table 1) .
Major complications were mainly due to respiratory failure, which occurred in nine cases (acute respiratory failure in five cases, recurrent atelectasis in three cases, with one case of ARDS). Three patients required intubation and six were successfully treated by non-invasive ventilation.
Two patients developed transient respiratory failure with evidence of diaphragmatic elevation; two patients had recurrent inhalations due to right laryngeal nerve palsy and one patient required tracheostomy for bilateral cordal damage.
One patient required surgery for haemothorax. Two additional patients developed haemothorax, which resolved after suspension of anticoagulation. Eleven patients (15.2%) required blood transfusions (median 3 units).
SVC system complications
In-hospital graft thrombosis occurred twice, in one case after PTFE replacement and the other after pericardial patch repair. Both were successfully treated by anticoagulation. After prosthetic replacement, three cases of early acute SVC syndrome without radiological evidence of prosthetic thrombosis were recorded, all of which after ligation of the azygos vein. The patients fully recovered within 3 weeks, once that collateral circulation was established.
Four months after surgery, all patents had enhanced chest CT scan results. At that time, no additional case of venous thrombosis was recorded. One patient was still on oxygen therapy due to chronic respiratory failure following right pneumonectomy. In one patient with N2 disease, cerebral metastases were discovered 4 months later due to the acute onset of neurological symptoms.
Risk factors
In terms of overall mortality and morbidity, univariate analysis did not confirm SVC replacement as having a detrimental effect as compared with SVC repair, given that major postoperative complications occurred in similar proportions in both groups (respectively, 6/28, 21.4% vs 7/44, 15.9%, p = 0.54, Table 2 ). However, regarding surgical complications, graft replacement increased the level of risk as compared to repair (odds ratio (OR) 6.05, confidence interval (CI): 1.07-33.9, p 0.03). In addition, in cases of vascular replacement, a trend towards an increased risk of phrenic and/or right laryngeal nerve damage was recorded (10.7% vs 2.2%, p = 0.15).
No other factor was identified at univariate analysis as a predictor of mortality or postoperative complications (Table 3) . Nevertheless, a trend towards a different type of risk was identified according to the site of the primary tumour in terms of respiratory complications, which were more frequent in mediastinal disease than in lung cancer patients (17.8% vs 9.1%, p = 0.2). By contrast, respiratory morbidity was limited when bronchoplasty avoided pneumonectomy (1/17 vs 4/11, p = 0.15). 
Conclusions
When resection of the superior vena cava is planned, three possible risks should be taken into account.
The first risk is potential overtreatment, as it is well known that the infiltration of the vessel established by clinical staging and intra-operative judgement may not be confirmed by the pathologist in about 30% of patients [9] .
The second is represented by intra-operative acute physiopathological modifications occurring during crossclamping. In this regard, intra-operative mediastinal syndrome during SVC syndrome did not represent a clinically relevant problem, as no neurological problem was recorded and side effects (i.e., facial and arms oedema) rapidly disappeared postoperatively. On the contrary, we recorded three cases of early postoperative SVC syndrome without thrombosis of the graft, requiring prolonged ICU stay. In all cases, only one BCV was reconstructed, the azygos vein was ligated, and in two patients the proximal anastomosis was on the right atrium. Considering these elements, one possible explanation is a functional failure of the venous system causing inadequate venous return against resistance (represented by pectinate muscles of the right atrium), resolved once collateral circulation was established. Finally, hypotension at crossclamping represented a limited problem, which occurred in 15% of patients, and was easily corrected in all but one case.
The third theoretical risk is represented by prosthetic replacement. In this regard, results from this study suggested that complete graft replacement of the SVC does not necessarily signify an increased rate of overall postoperative morbidity and can be considered a safe option when partial SVC resection is not feasible. Another issue is the choice of the best prosthetic material. Even if the risk of thrombosis was about 10% in our experience, ringed PTFE prosthesis remains our favourite choice, as the rigidity of the reconstruction does not allow compression due to surrounding structures at closure (sternum) and does not modify when mediastinal fibrosis due to surgical scars or radiotherapy [10] occurs. Several authors have advocated the use of soft customised pericardium prosthesis [11] [12] [13] , as it avoids the need for anticoagulation, and reported a lower risk of prosthetic thrombosis. At present, this improvement has yet to be confirmed in terms of long-term patency and, in our opinion, the available data do not support the choice of a different material.
Analysis of postoperative outcome revealed the presence of a fourth additional risk regarding SVC surgery, mediastinal nerve damage. The phrenic nerve is often resected en bloc with the vessel in the case of extensive SVC infiltration and it generally does not create problems after pneumonectomy or when diaphragmatic plication is performed at the end of the operation. Venous dissection at the top of the mediastinum may damage the right laryngeal nerve, causing hoarseness and possibly inhalation. The risk of bilateral damage exists in the case of huge mediastinal masses where the left laryngeal nerve is also at risk. When the nerve is damaged and vocal chords remain in either a median or paramedian position, urgent tracheotomy may be required after extubation (one patient in our series).
The retrospective nature of the study and the relatively small number of patients represent a clear limitation of the study. However, retrospective reports may add interesting observations on particular topics, such as SVC replacement, which represents an infrequent procedure for which each centre has standardised its own technique, and it is difficult to obtain additional information from controlled clinical trials [12] .
In conclusion, the study showed that complete prosthetic replacement with PTFE does not increase overall postoperative morbidity in patients undergoing SVC resection and can be safely performed when other reconstruction techniques preclude sufficient tumour-free resection margin or compromise adequate blood flow.
